/Companies

GEMMABio

Philadelphia, US · 5 known investors

Find your way into GEMMABio

Sign up to find every way you can get introduced to GEMMABio

  • Your email: who you already know at GEMMABio, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the GEMMABio team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

GEMMABio is a biotechnology company developing gene therapies for rare diseases using next-generation AAV technology, with programs spanning motor neuron disorders and skeletal and cardiomyopathies. It focuses on making treatments accessible to patients globally, with an emphasis on the rare disease community.

Founders & leadership

JMJames M. Wilson
James M. WilsonFounder

Investors · 5

Also in the syndicate · 2

Double Point VenturesleadSavanne Life Sciences

Funding

SEC filings, press & company announcements

$34M disclosed across 1 of 2 rounds · 2024–2025

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Frequently asked questions

What does GEMMABio do?
GEMMABio is a biotechnology company developing gene therapies for rare diseases using next-generation AAV technology, with programs spanning motor neuron disorders and skeletal and cardiomyopathies. It focuses on making treatments accessible to patients globally, with an emphasis on the rare disease community.
Who founded GEMMABio?
GEMMABio was founded by James M. Wilson.
Who are GEMMABio's investors?
GEMMABio's investors include IKJ Capital, Bioluminescence Ventures, Earlybird Venture Capital.
How much funding has GEMMABio raised?
GEMMABio has disclosed $34M raised across 1 of its 2 known rounds.
Where is GEMMABio headquartered?
GEMMABio is headquartered in Philadelphia, US.